Free shipping on all orders over $ 500

VP01

Cat. No. M50177

All AbMole products are for research use only, cannot be used for human consumption.

VP01 Structure

Price and Availability

For this product's availability, delivery time and price, please email inquiry@abmole.com directly or click the "Inquiry Now" button below.


Quality Control & Documentation
Biological Activity

VP01 is an orally active, low molecular weight angiotensin II-2 type 2 receptor (AT2R) agonist for studies related to idiopathic pulmonary fibrosis (IPF).

Chemical Information
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Related Angiotensin Receptor Products
Azilsartan medoxomil

Azilsartan Medoxomil is an effective angiotensin II Type 1 (AT1) receptor antagonist that inhibits RAAS more than 10,000 times more selectively than AT2, and is used to study hypertension.

Azilsartan

Azilsartan (TAK-536) is an angiotensin II type 1 (AT1) receptor antagonist with IC50 of 2.6 nM. Azilsartan induces ROS formation and apoptosis in HepG2 cells. Azilsartan shows neuroprotective and anticancer activity.

PD 123319 ditrifluoroacetate

PD 123319 ditrifluoroacetate is a potent, selective, non-peptide angiotensin AT2 receptor antagonist.

Losartan potassium

Losartan potassium is a selective non-peptide angiotensin AT1 receptor antagonist.

Eprosartan Mesylate

Eprosartan is a nonpeptide angiotensin II receptor antagonist, [3H]-eprosartan binds to the AT1 receptor with KD of 0.83 nM in rat vascular smooth muscle cells.

  Catalog
Abmole Inhibitor Catalog




Keywords: VP01 supplier, Angiotensin Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.